Literature DB >> 24426402

Correlation of biochemical markers of primary hyperparathyroidism with single adenoma weight and volume.

F Kamani1, A Najafi2, S S Mohammadi1, S Tavassoli2, S P Shojaei2.   

Abstract

Preoperative laboratory markers of primary hyperparathyroidism including serum parathormone (PTH), calcium and phosphate level may have some predictive value about the size and volume of the abnormal parathyroid gland tissue which needs to be resected in primary hyperparathyroidism. In a Prospective study from 2003 to 2010, 69 patients with parathyroid adenoma were enrolled. The correlation between preoperative serum PTH, calcium and phosphate level with adenoma's weight and volume was analyzed separately. Adenoma volume was calculated via an equation for the volume of a spheroid object. The data were analyzed via a multiple analysis of variance, and a correlation coefficient was calculated. The level of significance was set at p _ .05. There was a significant correlation between adenoma weight and serum calcium and parathormone levels (p = .0001 and p = .0001, respectively). There was no significant correlation between adenoma weight and serum phosphate. With respect to adenoma weight, there was a significant relationship with parathormone levels and serum calcium (p = .0001 and p = .0001, respectively). There was no significant relationship between serum phosphate and aden2oma weight. Preoperative serum PTH and calcium levels may be valuable in predicting parathyroid adenoma volume and weight in primary hyperparathyroidism for a single adenoma.

Entities:  

Keywords:  Adenoma; Biochemical markers; Primary hyperparathyroidism; Volume; Weight

Year:  2012        PMID: 24426402      PMCID: PMC3644162          DOI: 10.1007/s12262-012-0428-5

Source DB:  PubMed          Journal:  Indian J Surg        ISSN: 0973-9793            Impact factor:   0.656


  13 in total

1.  Intraoperative localization of parathyroid glands using methylthionine chloride / tetramethylthionine chloride in secondary hyperparathyroidism.

Authors:  K I Bland; S Tidwell; J A von Fraunhofer; R R Morris; M T McCoy; R L Wathen
Journal:  Surg Gynecol Obstet       Date:  1985-01

2.  The predictive value of laboratory findings in patients with primary hyperparathyroidism.

Authors:  Géza Mózes; Kathleen J Curlee; Charles M Rowland; Jon A van Heerden; Geoffrey B Thompson; Clive S Grant; David R Farley
Journal:  J Am Coll Surg       Date:  2002-02       Impact factor: 6.113

3.  The relation of serum calcium and immunoparathormone levels to parathyroid size and weight in primary hyperparathyroidism.

Authors:  R Rutledge; M Stiegel; C G Thomas; R E Wild
Journal:  Surgery       Date:  1985-12       Impact factor: 3.982

Review 4.  Primary hyperparathyroidism. A surgical perspective.

Authors:  O H Clark; Q Y Duh
Journal:  Endocrinol Metab Clin North Am       Date:  1989-09       Impact factor: 4.741

5.  Impact of technetium-99m-sestamibi localization on operative time and success of operations for primary hyperparathyroidism.

Authors:  A T Casas; G J Burke; A R Mansberger; J P Wei
Journal:  Am Surg       Date:  1994-01       Impact factor: 0.688

6.  Prospective comparison of technetium-99m-sestamibi/iodine-123 radionuclide scan versus high-resolution ultrasonography for the preoperative localization of abnormal parathyroid glands in patients with previously unoperated primary hyperparathyroidism.

Authors:  A T Casas; G J Burke; A R Mansberger; J P Wei
Journal:  Am J Surg       Date:  1993-10       Impact factor: 2.565

7.  The relationship between adenoma weight and intact (1-84) parathyroid hormone level in primary hyperparathyroidism.

Authors:  J G Williams; M H Wheeler; J P Aston; R C Brown; J S Woodhead
Journal:  Am J Surg       Date:  1992-03       Impact factor: 2.565

8.  Preoperative localization of parathyroid tissue with technetium-99m sestamibi 123I subtraction scanning.

Authors:  P Thulé; K Thakore; J Vansant; W McGarity; C Weber; L S Phillips
Journal:  J Clin Endocrinol Metab       Date:  1994-01       Impact factor: 5.958

9.  Parathyroid adenoma weight and the risk of death after treatment for primary hyperparathyroidism.

Authors:  G Hedbäck; A Odén; L E Tisell
Journal:  Surgery       Date:  1995-02       Impact factor: 3.982

10.  Primary hyperparathyroidism: do perioperative biochemical variables correlate with parathyroid adenoma weight or volume?

Authors:  P S Randhawa; A D Mace; S A R Nouraei; M P Stearns
Journal:  Clin Otolaryngol       Date:  2007-06       Impact factor: 2.597

View more
  6 in total

1.  Giant parathyroid tumours in primary hyperparathyroidism: a systematic review.

Authors:  Ho Kiu Grace Wong; Kate Shipman; Kimberley Allan; Andrew Ghabbour; Farzad Borumandi
Journal:  Langenbecks Arch Surg       Date:  2022-01-18       Impact factor: 3.445

Review 2.  Primary hyperparathyroidism-related giant parathyroid adenoma (Review).

Authors:  Adina Ghemigian; Alexandra Ioana Trandafir; Eugenia Petrova; Mara Carsote; Ana Valea; Alexandru Filipescu; Ana-Maria Oproiu; Florica Sandru
Journal:  Exp Ther Med       Date:  2021-11-26       Impact factor: 2.447

3.  THE VOLUME OF SOLITARY PARATHYROID ADENOMA IS RELATED TO PREOPERATIVE PTH AND 25OH-D3, BUT NOT TO CALCIUM LEVELS.

Authors:  A Gatu; C Velicescu; A Grigorovici; R Danila; V Muntean; S J Mogoş; V Mogoş; C Vulpoi; C Preda; D Branisteanu
Journal:  Acta Endocrinol (Buchar)       Date:  2017 Oct-Dec       Impact factor: 0.877

4.  Correlation of perioperative biochemical variables with single adenoma weight in patients with primary hyperparathyroidism.

Authors:  Marios Papadakis; Norbert Weyerbrock; Hubert Zirngibl; Cornelia Dotzenrath
Journal:  BMC Surg       Date:  2020-11-30       Impact factor: 2.102

5.  Radioactive Parathyroid Adenomas on Sestamibi Scans: Low Parathyroid Hormone Secretory Potential and Large Volume.

Authors:  Sung Hye Kong; Jung Hee Kim; Sang Wan Kim; Chan Soo Shin
Journal:  Endocrinol Metab (Seoul)       Date:  2021-04-06

6.  Predictors of adenoma size and location in primary hyperparathyroidism.

Authors:  Barbara Filser; Verena Uslar; Dirk Weyhe; Navid Tabriz
Journal:  Langenbecks Arch Surg       Date:  2021-04-30       Impact factor: 3.445

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.